Skip to main content
OpenTrials

Clinical trial condition

Liposarcoma

Explore clinical trials studying Liposarcoma. Study availability and eligibility vary by location and protocol.

123 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Liposarcoma trial results

Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Liposarcoma, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 260 locations
View Trial Details
Recruiting

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

NCT06843967

Conditions
Dedifferentiated Liposarcoma, Liposarcoma, Liposarcoma, Myxoid, +12 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

NCT04031677

Conditions
Leiomyosarcoma, Liposarcoma, Neoplasms, +6 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health-Chao Family Comp CC and Ambulatory Care Irvine, California, United States
View all 175 locations
View Trial Details
Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

NCT05711615

Conditions
Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +24 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

NCT06541262

Conditions
Ewing Sarcoma, Liposarcoma, Myosarcoma, +19 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 23 locations
View Trial Details
Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293

Conditions
Dedifferentiated Liposarcoma, Leiomyosarcoma, Liposarcoma, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health Cancer Institute Lake Success, New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

NCT06881992

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +29 more
Locations
  • Investigative Site Chicago, Illinois, United States
  • Investigative Site Bethesda, Maryland, United States
  • Investigative Site Boston, Massachusetts, United States
  • Investigative Site Rochester, Minnesota, United States
View all 13 locations
View Trial Details

Related conditions